CORCEPT THERAPEUTICS INC Cost of Goods Sold (Deprecated 2018-01-31)
CORCEPT THERAPEUTICS INC (CORT) reported Cost of Goods Sold (Deprecated 2018-01-31) of $1.17 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-05-09
- CORCEPT THERAPEUTICS INC cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.17M, a 81.73% increase year-over-year.
- CORCEPT THERAPEUTICS INC cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.16M, a 106.24% increase year-over-year.
- CORCEPT THERAPEUTICS INC cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $976.00K, a 46.11% increase year-over-year.
- CORCEPT THERAPEUTICS INC cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $775.00K, a 81.92% increase year-over-year.
- CORCEPT THERAPEUTICS INC cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $3.55M, a 72.69% increase from fiscal 2016.
- CORCEPT THERAPEUTICS INC cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $2.06M, a 51.21% increase from fiscal 2015.
- CORCEPT THERAPEUTICS INC cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $1.36M, a 54.31% increase from fiscal 2014.
- CORCEPT THERAPEUTICS INC cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $882.00K.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $1.17M 10-Q · filed 2018-05-09 | $2.33M derived: sum of 2 quarters · filed 2018-05-09 | $3.31M derived: sum of 3 quarters · filed 2018-05-09 | $4.08M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.13M derived: sum of 2 quarters · filed 2018-02-28 | $2.91M derived: sum of 3 quarters · filed 2018-02-28 | $3.55M 10-K · filed 2018-02-28 |
| 2017-09-30 | $976.00K 10-Q · filed 2017-11-03 | $1.75M derived: sum of 2 quarters · filed 2017-11-03 | $2.40M 10-Q · filed 2017-11-03 | $2.96M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-06-30 | $775.00K 10-Q · filed 2017-08-02 | $1.42M 10-Q · filed 2017-08-02 | $1.98M derived: sum of 3 quarters · filed 2018-05-09 | $2.65M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-03-31 | $646.00K 10-Q · filed 2018-05-09 | $1.21M derived: sum of 2 quarters · filed 2018-05-09 | $1.88M derived: sum of 3 quarters · filed 2018-05-09 | $2.30M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $561.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $1.23M derived: sum of 2 quarters · filed 2018-02-28 | $1.66M derived: sum of 3 quarters · filed 2018-02-28 | $2.06M 10-K · filed 2018-02-28 |
| 2016-09-30 | $668.00K 10-Q · filed 2017-11-03 | $1.09M derived: sum of 2 quarters · filed 2017-11-03 | $1.50M 10-Q · filed 2017-11-03 | $1.86M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $426.00K 10-Q · filed 2017-08-02 | $829.00K 10-Q · filed 2017-08-02 | $1.19M derived: sum of 3 quarters · filed 2018-02-28 | $1.45M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $403.00K 10-Q · filed 2017-05-02 | $767.00K derived: sum of 2 quarters · filed 2018-02-28 | $1.02M derived: sum of 3 quarters · filed 2018-02-28 | $1.46M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $620.00K derived: sum of 2 quarters · filed 2018-02-28 | $1.06M derived: sum of 3 quarters · filed 2018-02-28 | $1.36M 10-K · filed 2018-02-28 |
| 2015-09-30 | $256.00K 10-Q · filed 2016-11-02 | $695.00K derived: sum of 2 quarters · filed 2016-11-02 | $997.00K 10-Q · filed 2016-11-02 | |
| 2015-06-30 | $439.00K 10-Q · filed 2016-08-03 | $741.00K 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | $302.00K 10-Q · filed 2016-05-04 | |||
| 2014-12-31 | $882.00K 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |